InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,226.76
(
-1.06%
)
Post# of 458317
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JB3729

Send PM Follow Ignore
Followers 82
Posts 3648
Boards Moderated 0
Alias Born 02/15/2010

JB3729

Re: McMagyar post# 71591

Saturday, 07/30/2016 5:46:13 PM

Saturday, July 30, 2016 5:46:13 PM

Post# of 458317
This 2a trial was not designed to show the maximum efficacy of A2-73 alone or A2-73 Plus. Yes, there are still 10mg doses, which are below the established efficacy dose. The Company is compiling the info they need for a successful phase 3. We all need to understand where we are in the trial progression process.

why didn't they Optiize the dosage in PART B?
You mean there are still people only getting 10Mg?
come on Anavex..this is an ADAPTIVE TRIAL..
Would think offering ALL PARTICIPANTS the OPTION
to go MONOTHERAPY ..would be reasonable at this point..

I don't want to post Aricept Side Effects everyday..but
they are not pretty..

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!